Kamada Ltd.Usage: WinRho® SDF is indicated for treating immune thrombocytopenia (ITP) in Rh(D)-positive patients and for suppressing Rh isoimmunization in non-sensitized Rh(D)-negative individuals during Rh-incompatible pregnancies or following incompatible transfusions. It is not approved for other causes of thrombocytopenia or immunoglobulin replacement therapy.